The three fields of “IT-based drug discovery”, “protein-protein interaction prediction”, and “genome bigdata analysis” form the pillars of our company’s business. We possess cutting-edge and unique technologies that match industry needs in all of these fields. As a venture company certified by Institute of Science Tokyo, we utilize our close networks with national and overseas universities/research institutes and are working to develop a new market to link advanced technology to industrial needs.
Predict drug metabolic pathways from physicochemical features
Fast compound prescreening by fragmentation
Virtual screening based on learning-to-rank
We provide IT-based drug discovery services using various software (seed screening “Spresso”, machine learning-based screening “PKRank”, drug clearance pathway prediction “CPathPred”) for drug discovery support calculation, developed at Institute of Science Tokyo, as well as contract development, research consulting and HR training.
Related articles (IT-based Drug Discovery)
We perform millions-scale protein-protein interaction predictions with the state-of-the-art high-performance protein-protein docking software called MEGADOCK. We have extensive experience in protein-protein complex structure modeling, exhaustive PPI predictions, and PPI-related target identification.
*The commercial version of MEGADOCK is exclusively licensed to us by Institute of Science Tokyo.
Protein-protein interaction predictions with supercomputing
Database of PPI prediction results based on tertiary structure data
We provide exhaustive PPI prediction service using MEGADOCK software, PPI analysis utilized MEGADOCK-Web database, developed at Institute of Science Tokyo, as well as contract development, research consulting, HR training, etc.
Related articles (Protein-Protein Interaction)
We perform large-scale metagenome (16S/WGS) information analysis using the world’s fastest high-sensitivity sequence homology analysis software (GHOSTZ). We have extensive experience in oral, intestinal and environmental metagenomic analysis.
*The commercial version of GHOSTZ is exclusively licensed to us by Institute of Science Tokyo.
A sequence homology search tool approximately 100 times faster than BLAST
A sequence homology search tool approximately 200 times faster than BLAST
A sequence homology search tool that utilizes GPU to further speed up GHOSTZ 5–7 times more
We provide genome data analysis service using the sequence homology search software developed at Institute of Science Tokyo, contract development, research consulting and HR training.
Related articles (Genome Bigdata Analysis)
We offer contract software development services, including bio/pharma data processing, AI-driven analysis, database construction, web service implementation, and cloud integration.
Examples:
We also provide proposals and construction of workstation and server environments suitable for AI applications and simulation calculations in the drug discovery field.
Examples:
Our researchers, with extensive expertise in IT drug discovery and bioinformatics, offer consulting and investigation services for research challenges in these areas.
Our researchers, with extensive expertise in IT drug discovery and bioinformatics, offer consulting and investigation services for research challenges in these areas.
We offer training workshops and develop educational materials to foster human resources in IT drug discovery and bioinformatics.
We organize and manage seminars and international symposia related to IT drug discovery and bioinformatics.
(Past Achievements)
AHeDD2019/IPAB2019 Joint Symposium
Trends in Artificial Intelligence and Molecular Simulation for Accelerating e-Drug Discovery
https://ahedd2019.ahead-biocomputing.co.jp/en/
